Home > Boards > US OTC > Medical - Healthcare > InVivo Therapeutics Holdings Corp (NVIV)

I contacted WIRB via email seeking information on

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
kingofthepuppies Member Profile
 
Followed By 0
Posts 2
Boards Moderated 0
Alias Born 03/14/19
160x600 placeholder
InVivo Therapeutics gibt Vertagung der Hauptversammlung bekannt Business Wire - 6/14/2019 1:21:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2019 8:06:21 AM
InVivo Therapeutics Announces Adjournment of Annual Meeting Business Wire - 6/14/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/14/2019 7:51:21 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:10:45 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/5/2019 8:07:49 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/30/2019 6:01:28 AM
InVivo Therapeutics Announces Enrollment of First Two Patients into the INSPIRE 2.0 Study for the Treatment of Acute Spinal C... Business Wire - 5/29/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/22/2019 5:56:59 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 5/17/2019 4:37:53 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/10/2019 8:03:06 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/25/2019 5:22:49 PM
InVivo Therapeutics Announces Presentation of Twelve-Month Results from the INSPIRE Study of the Investigational Neuro-Spinal... Business Wire - 4/17/2019 8:00:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/15/2019 5:14:37 PM
InVivo Therapeutics Reports 2018 Year-end Financial Results and Provides Business Update Business Wire - 4/1/2019 8:15:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/1/2019 8:10:25 AM
Annual Report (10-k) Edgar (US Regulatory) - 4/1/2019 8:04:59 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/20/2019 6:31:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/20/2019 4:13:26 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 1:48:59 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2019 1:46:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/16/2019 4:43:10 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 1/16/2019 4:41:27 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 1/14/2019 5:31:18 PM
kingofthepuppies   Sunday, 03/31/19 05:08:22 PM
Re: None
Post # of 6117 
I contacted WIRB via email seeking information on the status of medical centers involved in the INSPIRE2 trial. Their email response stated they were unable to confirm participation in the study.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist